首页> 外文期刊>Progress in Neuro-Psychopharmacology & Biological Psychiatry: An International Research, Review and News Journal >Not only dopamine D 2 receptors involved in Peony-Glycyrrhiza Decoction, an herbal preparation against antipsychotic-associated hyperprolactinemia
【24h】

Not only dopamine D 2 receptors involved in Peony-Glycyrrhiza Decoction, an herbal preparation against antipsychotic-associated hyperprolactinemia

机译:不仅有多巴胺D 2受体参与牡丹-甘草汤,一种抗精神病相关的高泌乳素血症的草药制剂

获取原文
获取原文并翻译 | 示例
       

摘要

Clinical studies have demonstrated the effectiveness of an herbal preparation called Peony-Glycyrrhiza Decoction (PGD) in alleviating antipsychotic-induced hyperprolactinemia (hyperPRL). In the present study, we further examined the pharmacological action of PGD on prolactin (PRL) secretion using in vitro and in vivo models, with specific attention to the role of dopaminergic mediators and other sex hormones. Treatment with PGD at 1-5mg/ml significantly suppressed PRL secretion and synthesis in MMQ cells, a model of hyperPRL derived from pituitary adenoma cells. The suppressive effects were completely abolished by pretreatment with 10μM haloperidol, a dopamine D 2 receptor antagonist. Consistent with a D 2-action, PGD did not affect PRL in rat pituitary lactotropic tumor-derived GH3 cells that lack the D 2 receptor expression but significantly increased the expression of D 2 receptors and dopamine transporters (DAT) in PC12 cells. In a rat model of hyperPRL, produced by repeated injection of the dopamine blocker metoclopramide (MCP), chronic PGD (2.5-10g/kg daily) significantly reduced elevated serum PRL. The reduction in magnitude was similar to that elicited by bromocriptine (BMT), a dopamine D 2 receptor agonist currently used for treatment of hyperPRL. Neither PGD nor BMT altered serum estradiol, but PGD reversed decreased serum progesterone to control level, whereas BMT did not. These results indicate that the anti-hyperPRL effects of PGD are associated not only with D 2 receptor and DAT modulation, but also with a normalization of other sex hormone dysfunction. This experimental evidence supports clinical use of PGD as an effective treatment of antipsychotic-induced hyperPRL.
机译:临床研究表明,一种名为“牡丹-甘草汤”(PGD)的草药制剂可减轻抗精神病药物引起的高泌乳素血症(hyperPRL)。在本研究中,我们进一步使用体外和体内模型研究了PGD对催乳素(PRL)分泌的药理作用,特别注意多巴胺能介质和其他性激素的作用。 1-5mg / ml的PGD处理可显着抑制MMQ细胞中PRL的分泌和合成,MMQ细胞是来自垂体腺瘤细胞的hyperPRL模型。通过用10μM氟哌啶醇(一种多巴胺D 2受体拮抗剂)进行预处理,完全消除了抑制作用。与D 2作用一致,PGD不会影响大鼠垂体促乳腺肿瘤衍生的GH3细胞中的PRL,而GH3细胞缺乏D 2受体表达,但会显着增加PC12细胞中D 2受体和多巴胺转运蛋白(DAT)的表达。在通过多次注射多巴胺阻滞剂甲氧氯普胺(MCP)产生的hyperPRL大鼠模型中,慢性PGD(每天2.5-10g / kg)显着降低了血清PRL。幅度的降低与溴隐亭(BMT)引起的相似,溴隐亭是目前用于治疗hyperPRL的多巴胺D 2受体激动剂。 PGD​​和BMT均未改变血清雌二醇,但PGD逆转使血清孕酮降低至对照水平,而BMT未改变。这些结果表明,PGD的抗hyperPRL作用不仅与D 2受体和DAT调节有关,而且与其他性激素功能异常的正常化有关。该实验证据支持将PGD作为抗精神病药诱发的hyperPRL的有效治疗的临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号